Solara Active Pharma Sciences Limited — Credit Ratings, 01-07-2025: Credit Rating

Crisil Ratings has reaffirmed Solara Active Pharma Sciences Limited’s long-term credit rating at BBB with a stable outlook, upgrading the outlook from Negative, while the short-term rating remains A3+. This reflects an improvement in the company’s financial profile, particularly in its debt servicing capability and liquidity position. The stable outlook signals enhanced confidence in Solara’s ability to manage its Rs. 1484 Cr bank loan facilities effectively. This rating stability and outlook revision may result in better borrowing terms and increased investor trust, supporting Solara’s financial flexibility going forward.